sr141716 has been researched along with fm1 43 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, DJ; Thayer, SA | 1 |
| Kim, D; Thayer, SA | 1 |
2 other study(ies) available for sr141716 and fm1 43
| Article | Year |
|---|---|
Activation of CB1 cannabinoid receptors inhibits neurotransmitter release from identified synaptic sites in rat hippocampal cultures.
Topics: Animals; Benzoxazines; Calcium Channel Blockers; Cells, Cultured; Dronabinol; Fluorescent Dyes; Glutamic Acid; Hippocampus; Morpholines; Naphthalenes; Neural Inhibition; Neurons; Neurotransmitter Agents; Piperidines; Presynaptic Terminals; Psychotropic Drugs; Pyrazoles; Pyridinium Compounds; Quaternary Ammonium Compounds; Rats; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Stimulation, Chemical; Synaptic Transmission | 2000 |
Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture.
Topics: Animals; Arachidonic Acids; Benzoxazines; Cannabinoids; Cells, Cultured; Colforsin; Cyclic AMP; Dronabinol; Endocannabinoids; Fluorescent Dyes; Hippocampus; Morpholines; Naphthalenes; Neuronal Plasticity; Neurons; Piperidines; Polyunsaturated Alkamides; Presynaptic Terminals; Pyrazoles; Pyridinium Compounds; Quaternary Ammonium Compounds; Rats; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Synapses | 2001 |